MKMang Ke

Mang Ke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mang Ke has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Dechao Feng

    Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, China

    3 shared publications
  • Jie Wang

    Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China

    2 shared publications
  • Koo Han Yoo

    Department of Urology, Kyung Hee University, South Korea

    2 shared publications
  • Luxia Ye

    Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Publ Res Platform, Linhai, Peoples R China

    2 shared publications
  • Qin Feng

    Department of Urology Taizhou Hospital of Zhejiang Province Affiliated with Wenzhou Medical University Linhai China wmu.edu.cn

    2 shared publications
  • Qingxin Yu

    Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo City, Zhejiang Province, 315211, China

    2 shared publications

Latest Publications

  • Open Access

    Development and validation of a clinical nomogram based on lasso-logistic regression for predicting prostate cancer with PSA 4-20.0 ng/mL: a retrospective study

    by Mengling Ying, Lijun Wang, Mengge Yang, Mang Ke, Liangxue Sun

    Background: Given the established diagnostic utility of the prostate health index (PHI) in prostate cancer (PCa), this study sought to incorporate PHI into a clinically applicable prediction model alongside conventional parameters, with the goal of refining biopsy selection in men presenting with PSA values of 4–20 ng/mL. Methods: We retrospectively collected clinical data from patients undergoing prostate biopsy at tertiary medical centers in China. Candidate variables were screened using least absolute shrinkage and selection operator (LASSO) regression, and the selected predictors were incorporated into a multivariable logistic regression model, which was subsequently presented as a nomogram. Model performance was evaluated in both the training and validation cohorts in terms of discrimination, calibration, and clinical utility. Results: A total of 314 patients were included, with 219 assigned to the training cohort and 95 to the validation cohort. LASSO regression identified prostate volume, blood glucose, low-density lipoprotein, triglycerides, urinary leukocyte count, hypertension, Prostate Imaging–Reporting and Data System score, platelet-to-lymphocyte ratio, albumin, the fPSA/tPSA ratio, and PHI as candidate variables. Multivariate analysis demonstrated that triglycerides, PI-RADS score, ALB, and PHI were independent predictors of PCa. The nomogram achieved good discriminatory performance, with an area under the receiver operating characteristic curve of 0.75 in the training cohort. Calibration curves and the Hosmer–Lemeshow test indicated good agreement between predicted and observed outcomes. Consistent performance was observed in the validation cohort. Conclusions: Our findings suggest that integrating clinical parameters into a PHI-based model can enhance the stratification of prostate cancer risk, potentially reducing unnecessary biopsies and improving patient outcomes.

  • Open Access

    DMRT1 could serve as a prognostic biomarker for bladder cancer

    by Luxia Ye, Lingxiao Lu, Dechao Feng, Mang Ke

  • Open Access

    Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives

    by Dengxiong Li, Qingxin Yu, Ruicheng Wu, Zhouting Tuo, Jie Wang, Luxia Ye, Fanglin Shao, Premkamon Chaipanichkul, Koo Han Yoo, Wuran Wei, et al.


  • Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis

    by Dechao Feng, Yuhan Xiao, Jie Wang, Ruicheng Wu, Zhouting Tuo, Koo Han Yoo, Wuran Wei, Dilinaer Wusiman, Zhipeng Wang, Dengxiong Li, et al.

    Aging and circadian rhythms have been connected for decades, but their molecular interaction has remained unknown, especially for cancers. In this situation, we summarized the current research actuality and problems in this field using the bibliometric analysis. Publications in the PubMed and Web of Science databases were retrieved. Overall, there is a rising trend in the publication volume regarding aging and circadian rhythms in the field of cancer. Researchers from USA, Germany, Italy, China and England have greater studies than others. Top three publication institutions are University of California System, UDICE-French Research Universities and University of Texas System. Current research hotspots include oxidative stress, breast cancer, melatonin, cell cycle, calorie restriction, prostate cancer and NF-KB. In conclusion, results generated by bibliometric analysis indicate that many approaches involve in the complex interactions between aging and circadian rhythm in cancer. These established and emerging research directions guide our exploration of the regulatory mechanisms of aging and circadian rhythms in cancer and provide a reference for developing new research avenues.


  • Open Access

    PRR7 could serve as a prognostic biomarker for prostate cancer patients

    by Yiqing Guo, Qingxin Yu, Mang Ke, Jiaochen Wang


  • Open Access

    Health Behaviours among Travellers Regarding Risk Compensation Following COVID‐19 Vaccination in Taizhou, China

    by Meng-Ge Yang, Li-Jun Wang, Lu-Yin Xu, Mang Ke, Liang-Xue Sun

    Background. During the COVID‐19 pandemic, public transport was restricted in many countries because of the transmission risk. According to the risk compensation theory, travellers post‐COVID‐19 vaccination may encounter higher risks; however, no real‐world studies provide such evidence. Therefore, we conducted a survey to assess whether risk compensation would occur among travellers’ health‐related behaviours after COVID‐19 vaccination, potentially aggravating the transmission of the virus. Materials and Methods. A self‐administered online survey was designed and distributed over WeChat to identify the difference in health behaviours before and after COVID‐19 vaccination among travellers at a train station in Taizhou, China, from 13 February to 26 April 2022. Results. A total of 602 individuals completed the questionnaire. The results revealed no statistical difference between the health behaviours reported by the vaccinated and unvaccinated groups. Participants who received the first dose of the vaccine earlier showed no statistical difference in harmful health behaviours (hand washing frequency decreased by 4.1% (P = 0.145) and the duration of public transport travel increased by 3.4% (P = 0.437)), but showed better protective health behaviours (mask‐wearing duration increased by 24.7% (P = 0.014)). Compared to those vaccinated less than three times, participants vaccinated against COVID‐19 three times showed no statistical differences in harmful health behaviours mask‐wearing duration decreased by 7.0% (P = 0.927), their hand washing frequency decreased by 4.8% (P = 0.905), and the duration of public transport travel increased by 2.5% (P = 0.287). After vaccination, when compared to themselves before vaccination, participants exhibited better health behaviours (increased hand washing frequency and mask‐wearing duration, and decreased duration of public transport travel) to some extent. Conclusion. In conclusion, this study found no evidence of risk compensation among travellers. After being vaccinated, health behaviours partly improved among travellers.


  • Open Access

    High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration

    by Songzhe Piao, Lan Zheng, Haihong Zheng, Mengya Zhou, Qin Feng, Suna Zhou, Mang Ke, Haihua Yang, Xuequan Wang

    Purpose. To elucidate the clinical and prognostic role of PDZ and LIM domain protein (PDLIM) genes and the association to epithelial-mesenchymal transition (EMT) and immune cell infiltration in patients with prostate cancer (PRAD). Methods. The data of RNA-seq, DNA methylation, and clinical features of PRAD patients were collected from The Cancer Genome Atlas (TCGA) database to define the prognostic value of PDLIM gene expression and the association with EMT and immune cell infiltration. A tissue microarray including 134 radical prostatectomy specimens was served as validation by immunohistochemistry (IHC) staining analysis. Results. The mRNA levels of PDLIM1/2/3/4/6/7 were significantly downregulated, while PDLIM5 was upregulated in PRAD ( ). High expression of PDLIM2 mRNA suggests poor progression free interval in PRAD patients. DNA methylation of PDLIM2 was correlated with its mRNA expression level, and that the cg22973076 methylation site in PDLIM2 was associated with shorter PFI ( ) in PRAD. Single-sample gene-set enrichment and gene functional enrichment results showed that PDLIM2 was correlated with EMT and immune processes. Spearman’s test showed a significant correlation with six reported EMT signatures and several EMT signature-related genes. Tumor microenvironment analysis revealed that the PDLIM2 mRNA expression was positively correlated with the immune score, stromal score, and various tumor infiltrating immune cells. Additionally, the results showed that patients in the high-PDLIM2 mRNA expression group may be more sensitive to immune checkpoint blockade therapy. Finally, IHC analysis further implicated the protein level of PDLIM2 was upregulated in PRAD and acts as a novel potential biomarker in predicting tumor progression. Conclusion. Our study suggests that PDLIM family genes might be significantly correlated with oncogenesis and the progression of PRAD. PDLIM2 correlated with EMT and immune cell infiltration by acting as an oncogene in PRAD, which may serve as a potential prognostic biomarker for PRAD patients.


  • Open Access

    Pelvic lipomatosis with cystitis glandularis managed with cyclooxygenase-2 inhibitor: A case report

    by Li-Cai Mo, Song-Zhe Piao, Hai-Hong Zheng, Tao Hong, Qin Feng, Mang Ke

    Pelvic lipomatosis (PL) is a rare benign condition with characteristic overgrowth of histologically benign fat and invasion and compression of pelvic organs, often leading to non-specific lower urinary tract symptoms (LUTS). Approximately 40% of patients with PL have cystitis glandularis (CG). The cause of PL combined with CG is poorly understood, and there is currently no effective treatment. Refractory CG with upper urinary tract obstruction even requires partial or radical bladder resection. In this case, a patient suffering from PL with CG was treated by transurethral resection of bladder tumour (TUR-BT) and oral administration of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor. The LUTS were alleviated, and the cystoscopy results improved significantly. Immunohistochemistry showed up-regulated COX-2 expression in the epithelium of TUR-BT samples, suggesting that COX-2 may participate in the pathophysiological process of PL combined with CG. We report for the first time that celecoxib may be an effective treatment strategy for PL combined with refractory CG.